Research X

X
precision medicine
causal inference
regulatory & policy
methodology
trial design
machine learning
data quality
applications
endpoints
access
X

Join our ongoing series of virtual presentations and discussions exploring the principles, practices and possibilities of applying RWE in oncology research.

Upcoming Virtual Events

Oct 27

Regulatory & Policy

Beyond synthetic controls: Near term opportunities for regulatory RWD
1:00 - 2:00PM ET
Live Q&A

Use of real-world evidence (RWE) in support of regulatory filings continues to be a key focus area among life sciences companies. As the field learns from regulator feedback about how RWE can meaningfully contribute to submissions, we begin to get a clearer picture of near-term opportunities for regulatory RWE. Hear from life science leaders about how their organizations have successfully applied RWE in recent regulatory submissions, as well as Flatiron’s evolving perspective on the use of RWE for regulatory use.

Event details

Future sessions to be announced

Past sessions

APPLICATIONS

The role of real-world data in tumor-agnostic drug development

Guests from:

Janssen, Merck, Foundation Medicine

Includes:

Session details

Q&A session

Session Clips

REGULATORY & POLICY

Applying RWE to regulatory applications

Guests from:

FDA, Janssen, Pfizer, Roche

Includes:

Session details

Q&A session

Transcript

Session Clips

Applications

Precision oncology: how RWD is advancing clinico-genomic research

Guests from:

Moores Cancer Center, Roche/Genentech, Bristol Myers Squibb, Foundation Medicine

Includes:

Session details

Q&A session

Transcript

Session Clips
Join the live presentations and discussions.
Register for ResearchX